This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Witkiewicz, A. K. Articles by Kleer, C. G. Search for Related Content PubMed PubMed Citation Articles by Witkiewicz, A. K. Articles by Kleer, C. G. Related Collections Oncogenesis Oncogenesis: Biomarkers

-Methylacyl-CoA Racemase Protein Expression Is Associated with the Degree of Differentiation in Breast Cancer Using Quantitative Image Analysis

¹ Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Departments of ² Pathology, ³ Surgery, and ⁴ Biostatistics; and ⁵ Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan

Requests for reprints: Celina G. Kleer, Department of Pathology, University of Michigan, 3510 MSRB1, 1150 West Medical Center Drive, Ann Arbor, MI 48109. Phone: 734-615-3448; Fax: 734-615-3441. E-mail: kleer{at}umich.edu

-Methylacyl-CoA racemase (AMACR) is an enzyme involved in the metabolism of fatty acids and is an important tissue biomarker in the prostate to distinguish normal glands from prostate cancer. Here, for the first time, we evaluated the expression of AMACR protein in normal breast, ductal carcinoma in situ, and invasive carcinomas. By immunofluorescence and immunohistochemistry, AMACR was seen in cytoplasmic granules consistent with a mitochondrial and peroxisomal localization. AMACR expression was determined by immunohistochemistry on 160 invasive carcinomas with long follow-up, using a high-density tissue microarray, and evaluated by two methods: standard pathology review and quantitative image analysis. AMACR was overexpressed in 42 of 160 (26%) invasive carcinomas, and it was associated with a decrease in tumor differentiation, a feature of aggressive breast cancer. Quantitative analysis allowed for better discrimination and more accurate evaluation of low-intensity staining. In conclusion, AMACR protein is expressed in normal breast and its expression seems to increase in invasive carcinomas. We observed stronger AMACR protein expression in high-grade carcinomas when compared with low-grade ones. Quantitative image analysis is a novel way to accurately and reproducibly evaluate immunohistochemistry in breast tissue samples using high-density tissue microarrays.

This article has been cited by other articles:

				W. Huang, Y. Zhang, S. Varambally, A. M. Chinnaiyan, M. Banerjee, S. D. Merajver, and C. G. Kleer Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1 Am. J. Pathol., April 1, 2008; 172(4): 893 - 904. [Abstract] [Full Text] [PDF]

				S. E. Daugherty, E. A. Platz, Y. Y. Shugart, M. D. Fallin, W. B. Isaacs, N. Chatterjee, R. Welch, W.-Y. Huang, and R. B. Hayes Variants in the {alpha}-Methylacyl-CoA Racemase Gene and the Association with Advanced Distal Colorectal Adenoma Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1536 - 1542. [Abstract] [Full Text] [PDF]

				J. H. Ostrander, A. R. Daniel, K. Lofgren, C. G. Kleer, and C. A. Lange Breast Tumor Kinase (Protein Tyrosine Kinase 6) Regulates Heregulin-Induced Activation of ERK5 and p38 MAP Kinases in Breast Cancer Cells Cancer Res., May 1, 2007; 67(9): 4199 - 4209. [Abstract] [Full Text] [PDF]

				R. Mehra, S. Varambally, L. Ding, R. Shen, M. S. Sabel, D. Ghosh, A. M. Chinnaiyan, and C. G. Kleer Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis Cancer Res., December 15, 2005; 65(24): 11259 - 11264. [Abstract] [Full Text] [PDF]